SCHEMBL1397352

SCHEMBL1397352

CC1(C)C2CC3CC(C2)CC1C3

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL6938407 0.76 HSD11B1 (0.32) MAPT
SCHEMBL4858945 0.73 MAPT (0.31) MAPTTP53GAA
SCHEMBL3418488 0.73 MAPT (0.31) MAPTTP53GAA
SCHEMBL40305 0.73 ALDH1A1 (0.33) MAPT
SCHEMBL9058205 0.73 SLC22A2 (0.32) MAPT
SCHEMBL19083712 0.73 HSD11B1 (0.32) MAPT
SCHEMBL1237995 0.73 LMNA (0.38)
SCHEMBL14411565 0.73 MAPT (0.31) MAPTTP53GAA
SCHEMBL17352397 0.73 ALDH1A1 (0.33) MAPT
SCHEMBL4612492 0.73 HSD11B1 (0.31) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109233441-A Composition for ink, nano-particular film and opto-electronic device 苏州星烁纳米科技有限公司 2019-01-18 CN claimed
CN-101511170-A Sublimable sustained release delivery system and method of making same OAKWOOD LAB LLC (US) 2009-08-19 CN claimed
EP-4053223-B1 COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS F2MB ENG UG HAFTUNGSBESCHRAENKT (DE) 2025-05-14 EP disclosed
US-20240174871-A1 Compositions for Use in Optical Measurement Technology Applications F2MB-ENGINEERING UG (DE) 2024-05-30 US disclosed
CN-117440992-A Use of a composition in optical measurement applications F2MB-工程公司 2024-01-23 CN disclosed
WO-2022184834-A1 COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS F2MB-ENGINEERING UG (DE) 2022-09-09 WO disclosed
EP-4053223-A1 COMPOSITIONS FOR USE IN OPTICAL MEASUREMENT TECHNOLOGY APPLICATIONS F2MB-Engineering UG (haftungsbeschränkt) (DE) 2022-09-07 EP disclosed
US-10998197-B2 Polymer and composition for forming organic film, substrate for manufacturing semiconductor apparatus, method for forming organic film, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-04 US disclosed
CN-109233441-A Composition for ink, nano-particular film and opto-electronic device 苏州星烁纳米科技有限公司 2019-01-18 CN disclosed
CN-101891570-B Process for producing adamantanol OSAKA ORGANIC CHEMICAL INDUSTRY LTD. (JP) 2015-09-16 CN disclosed
EP-2349993-A1 SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS BASF SE (DE) 2011-08-03 EP disclosed
WO-2004074242-A2 HALOGENATED OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-09-02 WO disclosed
EP-1392675-A1 SUBSTITUTED OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS Ciba SC Holding AG (CH) 2004-03-03 EP disclosed
EP-1344109-A2 ONIUM SALTS AND THE USE THEROF AS LATENT ACIDS Ciba SC Holding AG (CH) 2003-09-17 EP disclosed
WO-2003067332-A2 SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-08-14 WO disclosed
EP-1320785-A2 OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS Ciba SC Holding AG (CH) 2003-06-25 EP disclosed
WO-2002098870-A1 SUBSTITUTED OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-12-12 WO disclosed
WO-2002046507-A2 ONIUM SALTS AND THE USE THEROF AS LATENT ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-06-13 WO disclosed
WO-2002025376-A2 OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-03-28 WO disclosed
WO-1995001319-A1 OXIDATIVE COUPLING OF DIAMONDOIDS AND AROMATICS MOBIL OIL CORPORATION (US) 1995-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10998197-B2 Polymer and composition for forming organic film, substrate for manufacturing semiconductor apparatus, method for forming organic film, and patterning process CAD, APOB, SMCHD1 MAPT 918/4885TP53 3569/4885GAA 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.